Company Filing History:
Years Active: 2018-2020
Title: Russell Keay: Innovator in Analyte Extraction Technology
Introduction
Russell Keay is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of analyte extraction technology, particularly in the determination of glycopeptide antibiotics. With a total of 2 patents, his work has implications for personalized medicine and drug administration.
Latest Patents
One of Russell Keay's latest patents is an "Analyte extraction apparatus and method." This invention discloses a method and apparatus for determining the concentration of glycopeptide antibiotics, such as Vancomycin, in complex sample matrices. The process involves extracting the antibiotic from a metered portion of the sample matrix using an extraction material that has an affinity for the glycopeptide antibiotic. The extraction material is then exposed to an eluent to release the antibiotic, followed by the addition of a Gibbs reagent to determine the concentration of the antibiotic. This innovative method also includes designing a personalized drug administration regime based on the obtained concentration.
Career Highlights
Throughout his career, Russell Keay has worked with various companies, including Sphere Medical Limited and UCL Business Plc. His experience in these organizations has contributed to his expertise in the field of analyte extraction and antibiotic determination.
Collaborations
Russell has collaborated with notable individuals such as Natascha Kappeler and Rachel Anne McKendry. These collaborations have likely enriched his research and development efforts in the field.
Conclusion
Russell Keay's innovative work in analyte extraction technology showcases his commitment to advancing medical science. His patents and collaborations reflect his significant contributions to the field, particularly in improving drug administration methods.